Drug-coated balloons versus drug-eluting stents for de novo coronary lesions: a systematic review and meta-analysis of randomised trials

医学 传统PCI 血管成形术 经皮冠状动脉介入治疗 心肌梗塞 置信区间 临床终点 靶病变 荟萃分析 相对风险 内科学 随机对照试验 再狭窄 心脏病学 外科 观察研究 临床试验 冠状动脉疾病 介入心脏病学 支架 气球 经皮 系统回顾 放射科 病变
作者
Diego Mondragón,D. Garín,Stéphane Cook,Guido Knapp,M G De Togni,Serban Puricel,Pascal Meier
出处
期刊:Heart [BMJ]
卷期号:: heartjnl-2026 被引量:1
标识
DOI:10.1136/heartjnl-2026-328324
摘要

BACKGROUND: Drug-coated balloon (DCB) angioplasty has emerged as a potential stent-free strategy for percutaneous coronary intervention (PCI) in de novo coronary artery disease, but robust randomised evidence on safety and efficacy compared with drug-eluting stents (DES) remains limited. METHODS: We conducted a comprehensive systematic review and meta-analysis of randomised controlled trials comparing DCB angioplasty with DES for de novo coronary lesions in adult patients reporting clinical outcomes at ≥9 months. PubMed, Embase and Cochrane CENTRAL were searched from inception to October 2025 without language restriction; trial registries and reference lists were screened manually. Studies limited to in-stent restenosis, bifurcation PCI or observational designs were excluded. Data were extracted independently by two reviewers. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models (DerSimonian-Laird method with Hartung-Knapp adjustment). Heterogeneity was assessed with I² and τ² statistics and 95% prediction intervals were reported. Risk of bias was appraised with the Cochrane Risk of Bias 2 tool. RESULTS: Seven trials encompassing 7138 patients (DCB 3570; DES 3568) were included. At 12 months, the device-oriented composite endpoint (cardiac death, target vessel myocardial infarction and target lesion revascularisation) showed no difference between strategies (RR 1.02, 95% CI 0.63 to 1.64; p=0.93; I²=52%). Secondary outcomes were comparable: cardiac death (1.26, 0.75 to 2.14), target vessel MI (0.71, 0.36 to 1.39), target lesion revascularisation (1.09, 0.52 to 2.30) and target vessel revascularisation (0.98, 0.58 to 1.65). Sensitivity analysis supported the stability of the primary findings. Trials using sirolimus coated balloons demonstrated similar results. CONCLUSIONS: DCB angioplasty shows comparable short-term safety and efficacy to modern DES for de novo coronary disease. Long-term follow-up is necessary to confirm whether avoidance of permanent implants translates into clinical benefit. PROSPERO REGISTRATION NUMBER: CRD420251175063.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
茧茧发布了新的文献求助10
刚刚
CarryLJR的应助被shidewu采纳,获得10
1秒前
曼文完成签到,获得积分10
1秒前
李爱国的应助被发发疯吃饭采纳,获得10
2秒前
烟花的应助被发发疯吃饭采纳,获得10
2秒前
上官若男的应助被发发疯吃饭采纳,获得10
2秒前
上官若男的应助被发发疯吃饭采纳,获得10
2秒前
3秒前
4秒前
4秒前
慕慕发布了新的文献求助10
4秒前
852的应助被Snifikin采纳,获得10
4秒前
勤恳不惜完成签到,获得积分10
4秒前
充电宝的应助被朴实的以南采纳,获得10
4秒前
鹤立名堂完成签到 ,获得积分10
5秒前
被风吹过的路的应助被沐南采纳,获得10
5秒前
热心市民小红花的应助被yyyyy采纳,获得10
5秒前
5秒前
大个的应助被Irene采纳,获得10
5秒前
大个的应助被yyyyy采纳,获得30
5秒前
科目三的应助被JUAN123采纳,获得10
5秒前
酷仔仔完成签到,获得积分20
5秒前
lnx的应助被yyyyy采纳,获得100
5秒前
Akim的应助被yyyyy采纳,获得10
6秒前
情怀的应助被yyyyy采纳,获得10
6秒前
初景的应助被yyyyy采纳,获得20
6秒前
脑洞疼的应助被潇洒盼柳采纳,获得30
6秒前
共享精神的应助被yyyyy采纳,获得10
6秒前
烟花的应助被yyyyy采纳,获得10
6秒前
爆米花的应助被yyyyy采纳,获得10
7秒前
打打的应助被yyyyy采纳,获得150
7秒前
Tonsil01发布了新的文献求助20
7秒前
8秒前
8秒前
8秒前
tang发布了新的文献求助10
8秒前
9秒前
9秒前
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178582
求助须知:如何正确求助?哪些是违规求助? 9569391
关于积分的说明 21804062
捐赠科研通 7773535
什么是DOI,文献DOI怎么找? 3432871
关于科研通互助平台的介绍 2556860
邀请新用户注册赠送积分活动 2478451